One phlebotomist can oversee up to 3 Aletta machines, directly helping to address the current phlebotomist shortage and long ...

Genglycos significantly reduced total daily cornstarch intake and dose frequency in patients aged 8 years and older with GSDIa.

Non-US-born physicians care for larger proportion of patients living in underserved communities and requiring complex care.

While study did not reveal a causal link, authors advise reducing exposure, particularly to products with fragrances.

The approval was supported by data from the phase 3 OPTIMA trial, which enrolled 63 adults with FOP confirmed by an ACVR1 FOP ...

Intismeran autogene is a personalized mRNA therapy that targets a tumor's unique mutational signature to trigger an anticancer immune response.

Coverage slipped for every required shot, with declines in more than half of states for a second straight year.

Most cases accounted for by medication-related exposures, with acetaminophen alone most frequently implicated.

The non-pharmacologic nasal mist uses hydroxypropyl methylcellulose to form a protective physical barrier in the nasal passages, trapping and blocking airborne allergens.

Nearly 1 in 4 patients treated with lecanemab for mild cognitive impairment or mild Alzheimer disease (AD) with confirmed amyloid pathology develop amyloid-rela ...

The phase 3 ALKIVIA study met its primary endpoint, demonstrating significant and sustained improvements in disease activity and muscle strength for patients with active autoimmune myositis.

Many people with atypical Alzheimer disease (AD) do not meet eligibility criteria for anti-amyloid therapies (AAT), according to a study published online August 5 in Neurology. Dror Shir, MD, from the ...